Target intelligence / Profile preview

Mitochondrial ribosomal protein L16 (MRPL16)

Target
MRPL16
Molecular classification
Structural constituent of ribosome, Mitochondrial ribosomal protein (large subunit, 39S), Mitochondrial translation machinery component
01

Overview

Mitochondrial ribosomal protein L16 (MRPL16) is a protein encoded by nuclear DNA that is integrated into the large (39S) subunit of the mammalian mitochondrial ribosome. It plays a crucial role as a structural component in the assembly and stabilization of the mitochondrial ribosome required for protein translation within the mitochondrion. Unlike cytoplasmic ribosomal proteins, mitochondrial ribosomal proteins—including MRPL16—show significant sequence divergence among species, making their identification by homology more challenging. MRPL16 has been implicated in rare inherited mitochondrial disorders, such as combined oxidative phosphorylation deficiency, due to its essential role in mitochondrial gene expression and energy production. Its function is widely conserved in eukaryotes, and it is primarily involved in mitochondrial protein synthesis, but it is not considered a direct or actionable therapeutic target in pharmacology.

Other names
L16mtMRP-L16PNAS-111uL16m39S ribosomal protein L16FLJ20484mitochondrial large ribosomal subunit protein uL16m
02

Mechanism of action

Not applicable; no existing drugs target this protein directly.

03

Biological functions

Mitochondrial protein synthesisStructural support for mitochondrial ribosomerRNA binding
04

Disease associations

Combined oxidative phosphorylation deficiency 9Other mitochondrial translational disorders (potential, but not well characterized)
05

Safety considerations

None specific for therapeutic intervention; potential concern for mitochondrial dysfunction if mutated or deficient

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L16 (MRPL16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L16 (MRPL16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call